Sit Less, Interact and Move More (SLIMM) 2 Study
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 156 participants.
Also called NCT05173714
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 156 participants
- Registry
-
NCT05173714
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05173714. Randomized; quadruple masking; primary purpose treatment. Start 2021-12-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sit Less, Interact and Move More (SLIMM) 2 Study
- Condition
- Chronic Kidney Diseases
- Condition
- Obesity
- Intervention (Behavioral)
- SLIMM
- Intervention (Behavioral)
- Standard Resistance Training
- Intervention (Behavioral)
- Guided Resistance Training
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Semaglutide
- Lead sponsor
- Srinvasan Beddhu
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator
- Stanford University
Record details
- Record id
cardio:ct-nct05173714- Content hash
eb9e478d87bb6d7bd670b49b1232fd1152790a75399d219037bfc6c3b078f82e